{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DNA cleavage", "apoptosis", "colorectal cancer", "cytotoxicity", "molecular docking", "pharmacokinetic properties", "plastoquinones"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35163957", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "22"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "21"}], "Language": ["eng"], "ELocationID": ["693", "10.3390/molecules27030693"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "21"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment.", "Abstract": {"AbstractText": ["Plants have paved the way for the attainment of molecules with a wide-range of biological activities. However, plant products occasionally show low biological activities and/or poor pharmacokinetic properties. In that case, development of their derivatives as drugs from the plant world has been actively performed. As plant products, plastoquinones (<b>PQs</b>) have been of high importance in anticancer drug design and discovery; we have previously evaluated and reported the potential cytotoxic effects of a series of <b>PQ</b> analogs. Among these analogs, <b>PQ2</b>, <b>PQ3</b> and <b>PQ10</b> were selected for National Cancer Institute (NCI) for in vitro screening of anticancer activity against a wide range of cancer cell lines. The apparent superior anticancer potency of <b>PQ2</b> on the HCT-116 colorectal cancer cell line than that of <b>PQ3</b> and <b>PQ10</b> compared to other tested cell lines has encouraged us to perform further mechanistic studies to enlighten the mode of anti-colorectal cancer action of <b>PQ2</b>. For this purpose, its apoptotic effects on the HCT-116 cell line, DNA binding capacity and several crucial pharmacokinetic properties were investigated. Initially, MTT assay was conducted for <b>PQ2</b> at different concentrations against HCT-116 cells. Results indicated that <b>PQ2</b> exhibited significant cytotoxicity in HCT-116 cells with an IC<sub>50</sub> value of 4.97 \u00b1 1.93 \u03bcM compared to cisplatin (IC<sub>50</sub> = 26.65 \u00b1 7.85 \u03bcM). Moreover, apoptotic effects of <b>PQ2</b> on HCT-116 cells were investigated by the annexin V/ethidium homodimer III staining method and <b>PQ2</b> significantly induced apoptosis in HCT-116 cells compared to cisplatin. Based on the potent DNA cleavage capacity of <b>PQ2</b>, molecular docking studies were conducted in the minor groove of the double helix of DNA and <b>PQ2</b> presented a key hydrogen bonding through its methoxy moiety. Overall, both in vitro and in silico studies indicated that effective, orally bioavailable drug-like <b>PQ2</b> attracted attention for colorectal cancer treatment. The most important point to emerge from this study is that appropriate derivatization of a plant product leads to unique biologically active compounds."]}, "AuthorList": [{"Identifier": ["0000-0002-9796-7669"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Discovery, Science Farm Ltd., Kumamoto 862-0976, Japan."}, {"Identifier": [], "Affiliation": "Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan."}, {"Identifier": [], "Affiliation": "Department of Molecular Biology and Genetics, Koc University, Istanbul 34450, Turkey."}], "LastName": "Ciftci", "ForeName": "Halilibrahim", "Initials": "H"}, {"Identifier": ["0000-0003-4847-9711"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Turkey."}], "LastName": "Sever", "ForeName": "Belgin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Kocaeli University, Kocaeli 41001, Turkey."}], "LastName": "Ocak", "ForeName": "Firdevs", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Engineering, Istanbul University-Cerrahpasa, Istanbul 34320, Turkey."}], "LastName": "Bayrak", "ForeName": "Nil\u00fcfer", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Gebze Technical University, Kocaeli 41400, Turkey."}], "LastName": "Y\u0131ld\u0131z", "ForeName": "Mahmut", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Engineering, Istanbul University-Cerrahpasa, Istanbul 34320, Turkey."}], "LastName": "Y\u0131ld\u0131r\u0131m", "ForeName": "Hatice", "Initials": "H"}, {"Identifier": ["0000-0002-9135-5397"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Biology and Genetics, Koc University, Istanbul 34450, Turkey."}], "LastName": "DeMirci", "ForeName": "Hasan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan."}], "LastName": "Tateishi", "ForeName": "Hiroshi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Discovery, Science Farm Ltd., Kumamoto 862-0976, Japan."}, {"Identifier": [], "Affiliation": "Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan."}], "LastName": "Otsuka", "ForeName": "Masami", "Initials": "M"}, {"Identifier": ["0000-0001-6705-4052"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan."}], "LastName": "Fujita", "ForeName": "Mikako", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Istanbul University, Istanbul 34126, Turkey."}], "LastName": "TuYuN", "ForeName": "Ama\u00e7 Fatih", "Initials": "AF"}], "GrantList": [{"GrantID": "FBA-2017-24559", "Agency": "The Scientific Research Projects Coordination Unit of Istanbul University-Cerrahpasa", "Country": ""}, {"GrantID": "12C063", "Agency": "TUBITAK 2236 CoCirculation2", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "OAC30J69CN", "NameOfSubstance": "Plastoquinone"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Colorectal Neoplasms"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Plastoquinone"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2004;56:1649\u20131659. doi: 10.1016/j.addr.2004.02.014.", "ArticleIdList": ["10.1016/j.addr.2004.02.014", "15350294"]}, {"Citation": "Hebar A., Valent P., Selzer E. The impact of molecular targets in cancer drug development: Major hurdles and future strategies. Expert Rev. Clin. Pharmacol. 2013;6:23\u201334. doi: 10.1586/ecp.12.71.", "ArticleIdList": ["10.1586/ecp.12.71", "23272790"]}, {"Citation": "Gewirtz D.A., Bristol M.L., Yalowich J.C. Toxicity issues in cancer drug development. Curr. Opin. Investig. Drugs. 2010;11:612\u2013614.", "ArticleIdList": ["20496255"]}, {"Citation": "Cragg G.M., Grothaus P.G., Newman D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009;109:3012\u20133043. doi: 10.1021/cr900019j.", "ArticleIdList": ["10.1021/cr900019j", "19422222"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u2013477. doi: 10.1021/np068054v.", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Butler M.S. Natural products to drugs: Natural product-derived compounds in clinical trials. Nat. Prod. Rep. 2008;25:475\u2013516. doi: 10.1039/b514294f.", "ArticleIdList": ["10.1039/b514294f", "18497896"]}, {"Citation": "Collett N.P., Amin A.R.M.R., Bayraktar S., Pezzuto J.M., Shin D.M., Khuri F.R., Aggarwal B.B., Surh Y.J., Kucuk O. Cancer prevention with natural compounds. Semin. Oncol. 2010;37:258\u2013281.", "ArticleIdList": ["20709209"]}, {"Citation": "Begleiter A. Clinical applications of quinone-containing alkylating agents. Front. Biosci. 2000;5:E153\u2013E171. doi: 10.2741/A483.", "ArticleIdList": ["10.2741/A483", "11056078"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "de Almeida P.D.O., Jobim G.D.B., Ferreira C.C.D., Bernardes L.R., Dias R.B., Sales C.B.S., Valverde L.D., Rocha C.A.G., Soares M.B.P., Bezerra D.P., et al. A new synthetic antitumor naphthoquinone induces ROS-mediated apoptosis with activation of the JNK and p38 signaling pathways. Chem. Biol. Interact. 2021;343:109444. doi: 10.1016/j.cbi.2021.109444.", "ArticleIdList": ["10.1016/j.cbi.2021.109444", "33939975"]}, {"Citation": "Wellington K.W., Kolesnikova N.I., Nyoka N.B.P., McGaw L.J. Investigation of the antimicrobial and anticancer activity of aminonaphthoquinones. Drug Dev. Res. 2019;80:138\u2013146. doi: 10.1002/ddr.21477.", "ArticleIdList": ["10.1002/ddr.21477", "30284739"]}, {"Citation": "Wellington K.W. Understanding cancer and the anticancer activities of naphthoquinones\u2014A review. RSC Adv. 2015;5:20309\u201320338. doi: 10.1039/C4RA13547D.", "ArticleIdList": ["10.1039/C4RA13547D"]}, {"Citation": "Defant A., Mancini I. Design, synthesis and cancer cell growth inhibition evaluation of new aminoquinone hybrid molecules. Molecules. 2019;24:2224. doi: 10.3390/molecules24122224.", "ArticleIdList": ["10.3390/molecules24122224", "PMC6630839", "31197105"]}, {"Citation": "Nain-Perez A., Barbosa L.C.A., Rodriguez-Hernandez D., Kramell A.E., Heller L., Csuk R. Natural abenquines and synthetic analogues: Preliminary exploration of their cytotoxic activity. Bioorg. Med. Chem. Lett. 2017;27:1141\u20131144. doi: 10.1016/j.bmcl.2017.01.079.", "ArticleIdList": ["10.1016/j.bmcl.2017.01.079", "28169163"]}, {"Citation": "Aminin D., Polonik S. 1,4-Naphthoquinones: Some biological properties and application. Chem. Pharmacol. Bull. 2020;68:46\u201357. doi: 10.1248/cpb.c19-00911.", "ArticleIdList": ["10.1248/cpb.c19-00911", "31902901"]}, {"Citation": "Kruschel R.D., Buzid A., Khandavilli U.B.R., Lawrence S.E., Glennon J.D., McCarthy F.O. Isoquinolinequinone N-oxides as anticancer agents effective against drug resistant cell lines. Org. Biomol. Chem. 2020;18:557\u2013568. doi: 10.1039/C9OB02441G.", "ArticleIdList": ["10.1039/C9OB02441G", "31894828"]}, {"Citation": "Coutelle O., Hornig-Do H.T., Witt A., Andree M., Schiffmann L.M., Piekarek M., Brinkmann K., Seeger J.M., Liwschitz M., Miwa S., et al. Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing. EMBO Mol. Med. 2014;6:624\u2013639. doi: 10.1002/emmm.201303016.", "ArticleIdList": ["10.1002/emmm.201303016", "PMC4023885", "24648500"]}, {"Citation": "Asaduzzaman Khan M.A., Tania M., Fu S.Y., Fu J.J. Thymoquinone, as an anticancer molecule: From basic research to clinical investigation. Oncotarget. 2017;8:51907\u201351919. doi: 10.18632/oncotarget.17206.", "ArticleIdList": ["10.18632/oncotarget.17206", "PMC5584300", "28881699"]}, {"Citation": "Mostofa A.G.M., Hossain M.K., Basak D., Bin Sayeed M.S. Thymoquinone as a potential adjuvant therapy for cancer treatment: Evidence from preclinical studies. Front. Pharmacol. 2017;8:295. doi: 10.3389/fphar.2017.00295.", "ArticleIdList": ["10.3389/fphar.2017.00295", "PMC5466966", "28659794"]}, {"Citation": "Wang H., Zou C., Zhao W., Yu Y., Cui Y., Zhang H.E.F., Qiu Z., Zou C., Gao X. Juglone eliminates MDSCs accumulation and enhances antitumor immunity. Int. Immunopharmacol. 2019;73:118\u2013127. doi: 10.1016/j.intimp.2019.04.058.", "ArticleIdList": ["10.1016/j.intimp.2019.04.058", "31085459"]}, {"Citation": "Seetha A., Devaraj H., Sudhandiran G. Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J. Biochem. Mol. Toxicol. 2020;34:e22433. doi: 10.1002/jbt.22433.", "ArticleIdList": ["10.1002/jbt.22433", "31916655"]}, {"Citation": "Seetha A., Devaraj H., Sudhandiran G. Effects of combined treatment with indomethacin and juglone on AOM/DSS induced colon carcinogenesis in Balb/c mice: Roles of inflammation and apoptosis. Life Sci. 2021;264:118657. doi: 10.1016/j.lfs.2020.118657.", "ArticleIdList": ["10.1016/j.lfs.2020.118657", "33148421"]}, {"Citation": "Majiene D., Kuseliauskyte J., Stimbirys A., Jekabsone A. Comparison of the effect of native 1,4-naphthoquinones plumbagin, menadione, and lawsone on viability, redox status, and mitochondrial functions of C6 glioblastoma cells. Nutrients. 2019;11:1294. doi: 10.3390/nu11061294.", "ArticleIdList": ["10.3390/nu11061294", "PMC6628372", "31181639"]}, {"Citation": "Kawamukai M. Biosynthesis and applications of prenylquinones. Biosci. Biotechnol. Biochem. 2018;82:963\u2013977. doi: 10.1080/09168451.2018.1433020.", "ArticleIdList": ["10.1080/09168451.2018.1433020", "29457959"]}, {"Citation": "Boler J., Pardini R., Mustafa H.T., Folkers K., Dilley R.A., Crane F.L. Synthesis of plastoquinone analogs and inhibition of photosynthetic and mammalian enzyme systems. Proc. Natl. Acad. Sci. USA. 1972;69:3713\u20133717. doi: 10.1073/pnas.69.12.3713.", "ArticleIdList": ["10.1073/pnas.69.12.3713", "PMC389855", "4405029"]}, {"Citation": "Liu M.M., Lu S.F. Plastoquinone and ubiquinone in plants: Biosynthesis, physiological function and metabolic engineering. Front. Plant Sci. 2016;7:1898. doi: 10.3389/fpls.2016.01898.", "ArticleIdList": ["10.3389/fpls.2016.01898", "PMC5159609", "28018418"]}, {"Citation": "Jannuzzi A.T., Y\u0131ld\u0131z M., Bayrak N., Y\u0131ld\u0131r\u0131m H., Shilkar D., Jayaprakash V., Tuyun A.F. Anticancer agents based on Plastoquinone analogs with N-phenylpiperazine: Structure-activity relationship and mechanism of action in breast cancer cells. Chem. Biol. Interact. 2021;349:109673. doi: 10.1016/j.cbi.2021.109673.", "ArticleIdList": ["10.1016/j.cbi.2021.109673", "34560069"]}, {"Citation": "Bayrak N., Yildirim H., Yildiz M., Radwan M.O., Otsuka M., Fujita M., Ciftci H.I., Tuyun A.F. A novel series of chlorinated plastoquinone analogs: Design, synthesis, and evaluation of anticancer activity. Chem. Biol. Drug Des. 2020;95:343\u2013354. doi: 10.1111/cbdd.13651.", "ArticleIdList": ["10.1111/cbdd.13651", "31785034"]}, {"Citation": "Bayrak N., Yildirim H., Yildiz M., Radwan M.O., Otsuka M., Fujita M., Tuyun A.F., Ciftci H.I. Design, synthesis, and biological activity of Plastoquinone analogs as a new class of anticancer agents. Bioorg. Chem. 2019;92:103255. doi: 10.1016/j.bioorg.2019.103255.", "ArticleIdList": ["10.1016/j.bioorg.2019.103255", "31542717"]}, {"Citation": "Ciftci H.I., Bayrak N., Yildirim H., Yildiz M., Radwan M.O., Otsuka M., Fujita M., Tuyun A.F. Discovery and structure-activity relationship of plastoquinone analogs as anticancer agents against chronic myelogenous leukemia cells. Arch. Pharmacol. 2019;352:1900170. doi: 10.1002/ardp.201900170.", "ArticleIdList": ["10.1002/ardp.201900170", "31602720"]}, {"Citation": "Yildirim H., Bayrak N., Yildiz M., Kara E.M., Celik B.O., Tuyun A.F. Thiolated plastoquinone analogs: Synthesis, characterization, and antimicrobial evaluation. J. Mol. Struct. 2019;1195:681\u2013688. doi: 10.1016/j.molstruc.2019.05.076.", "ArticleIdList": ["10.1016/j.molstruc.2019.05.076"]}, {"Citation": "Yildirim H., Bayrak N., Tuyun A.F., Kara E.M., Celik B.O., Gupta G.K. 2,3-Disubstituted-1,4-naphthoquinones containing an arylamine with trifluoromethyl group: Synthesis, biological evaluation, and computational study. RSC Adv. 2017;7:25753\u201325764. doi: 10.1039/C7RA00868F.", "ArticleIdList": ["10.1039/C7RA00868F"]}, {"Citation": "Ibis C., Ozsoy-Gunes Z., Tuyun A.F., Ayla S.S., Bahar H., Stasevych M.V., Musyanovych R.Y., Komarovska-Porokhnyavets O., Novikov V. Synthesis, antibacterial and antifungal evaluation of thio- or piperazinyl-substituted 1,4-naphthoquinone derivatives. J. Sulfur Chem. 2016;37:477\u2013487. doi: 10.1080/17415993.2016.1187734.", "ArticleIdList": ["10.1080/17415993.2016.1187734"]}, {"Citation": "Tuyun A.F., Bayrak N., Yildirim H., Onul N., Kara E.M., Celik B.O. Synthesis and in vitro biological evaluation of aminonaphthoquinones and benzo[b]phenazine-6,11-dione derivatives as potential antibacterial and antifungal compounds. J. Chem. 2015;2015:645902. doi: 10.1155/2015/645902.", "ArticleIdList": ["10.1155/2015/645902"]}, {"Citation": "Boyd M.R., Pauli K.D. Some practical considerations and applications of the National-Cancer-Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995;34:91\u2013109. doi: 10.1002/ddr.430340203.", "ArticleIdList": ["10.1002/ddr.430340203"]}, {"Citation": "Yin A., Jiang Y., Zhang X., Zhao J., Luo H. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. Eur. J. Pharmacol. 2010;649:120\u2013126. doi: 10.1016/j.ejphar.2010.09.040.", "ArticleIdList": ["10.1016/j.ejphar.2010.09.040", "20869960"]}, {"Citation": "Brogden A.L., Hopcroft N.H., Searcey M., Cardin C.J. Ligand bridging of the DNA Holliday junction: Molecular recognition of a stacked-X four-way junction by a small molecule. Angew. Chem. Int. Ed. Eng. 2007;46:3850\u20133854. doi: 10.1002/anie.200603760.", "ArticleIdList": ["10.1002/anie.200603760", "17477457"]}, {"Citation": "Colorectal Cancer.  [(accessed on 19 October 2021)].  Available online:  https://gco.iarc.fr/today/data/factsheets/cancers/10_8_9-Colorectum-fact-sheet.pdf."}, {"Citation": "Khalife R., Hodroj M.H., Fakhoury R., Rizk S. Thymoquinone from Nigella sativa seeds promotes the antitumor activity of noncytotoxic doses of topotecan in human colorectal cancer cells in vitro. Planta Med. 2016;82:312\u2013321. doi: 10.1055/s-0035-1558289.", "ArticleIdList": ["10.1055/s-0035-1558289", "26848703"]}, {"Citation": "Wirries A., Breyer S., Quint K., Schobert R., Ocker M. Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells. Exp. Ther. Med. 2010;1:369\u2013375. doi: 10.3892/etm_00000058.", "ArticleIdList": ["10.3892/etm_00000058", "PMC3445902", "22993551"]}, {"Citation": "Glamo\u010dlija U., Padhye S., \u0160pirtovi\u0107-Halilovi\u0107 S., Osmanovi\u0107 A., Veljovi\u0107 E., Roca S., Novakovi\u0107 I., Mandi\u0107 B., Turel I., Kljun J., et al. Synthesis, biological evaluation and docking studies of benzoxazoles derived from thymoquinone. Molecules. 2018;23:3297. doi: 10.3390/molecules23123297.", "ArticleIdList": ["10.3390/molecules23123297", "PMC6321291", "30545123"]}, {"Citation": "Kadela-Tomanek M., Jastrzebska M., Marciniec K., Chrobak E., Bebenek E., Latocha M., Kusmierz D., Boryczka S. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate. Bioorg. Chem. 2021;106:104478. doi: 10.1016/j.bioorg.2020.104478.", "ArticleIdList": ["10.1016/j.bioorg.2020.104478", "33272711"]}, {"Citation": "Mohammad R.M., Muqbil I., Lowe L., Yedjou C., Hsu H.Y., Lin L.T., Siegelin M.D., Fimognari C., Kumar N.B., Dou Q.P., et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 2015;35:S78\u2013S103. doi: 10.1016/j.semcancer.2015.03.001.", "ArticleIdList": ["10.1016/j.semcancer.2015.03.001", "PMC4720504", "25936818"]}, {"Citation": "Jia L.T., Chen S.Y., Yang A.G. Cancer gene therapy targeting cellular apoptosis machinery. Cancer Treat. Rev. 2012;38:868\u2013876. doi: 10.1016/j.ctrv.2012.06.008.", "ArticleIdList": ["10.1016/j.ctrv.2012.06.008", "22800735"]}, {"Citation": "Kruyt F.A., Schuringa J.J. Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy. Biochem. Pharmacol. 2010;80:423\u2013430. doi: 10.1016/j.bcp.2010.04.010.", "ArticleIdList": ["10.1016/j.bcp.2010.04.010", "20394737"]}, {"Citation": "Bold R.J., Termuhlen P.M., McConkey D.J. Apoptosis, cancer and cancer therapy. Surg. Oncol. 1997;6:133\u2013142. doi: 10.1016/S0960-7404(97)00015-7.", "ArticleIdList": ["10.1016/S0960-7404(97)00015-7", "9576629"]}, {"Citation": "Bayrak N., Ciftci H.I., Yildiz M., Yildirim H., Sever B., Tateishi H., Otsuka M., Fujita M., Tuyun A.F. Structure based design, synthesis, and evaluation of anti-CML activity of the quinolinequinones as LY83583 analogs. Chem. Biol. Interact. 2021;345:109555. doi: 10.1016/j.cbi.2021.109555.", "ArticleIdList": ["10.1016/j.cbi.2021.109555", "34146539"]}, {"Citation": "Ciftci H.I., Bayrak N., Y\u0131ld\u0131z M., Y\u0131ld\u0131r\u0131m H., Sever B., Tateishi H., Otsuka M., Fujita M., Tuyun A.F. Design, synthesis and investigation of the mechanism of action underlying anti-leukemic effects of the quinolinequinones as LY83583 analogs. Bioorg. Chem. 2021;114:105160. doi: 10.1016/j.bioorg.2021.105160.", "ArticleIdList": ["10.1016/j.bioorg.2021.105160", "34328861"]}, {"Citation": "Kim T., Park H. Computational prediction of octanol-water partition coefficient based on the extended solvent-contact model. J. Mol. Graph. Model. 2015;60:108\u2013117. doi: 10.1016/j.jmgm.2015.06.004.", "ArticleIdList": ["10.1016/j.jmgm.2015.06.004", "26142695"]}, {"Citation": "Hewitt M., Cronin M.T., Enoch S.J., Madden J.C., Roberts D.W., Dearden J.C. In silico prediction of aqueous solubility: The solubility challenge. J. Chem. Inf. Model. 2009;49:2572\u20132587. doi: 10.1021/ci900286s.", "ArticleIdList": ["10.1021/ci900286s", "19877720"]}, {"Citation": "Vallianatou T., Lambrinidis G., Tsantili-Kakoulidou A. In silico prediction of human serum albumin binding for drug leads. Expert Opin. Drug Discov. 2013;8:583\u2013595. doi: 10.1517/17460441.2013.777424.", "ArticleIdList": ["10.1517/17460441.2013.777424", "23461733"]}, {"Citation": "Pardridge W.M. Drug and gene delivery to the brain: The vascular route. Neuron. 2002;36:555\u2013558. doi: 10.1016/S0896-6273(02)01054-1.", "ArticleIdList": ["10.1016/S0896-6273(02)01054-1", "12441045"]}, {"Citation": "Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigrowolff A., et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 1991;83:757\u2013766. doi: 10.1093/jnci/83.11.757.", "ArticleIdList": ["10.1093/jnci/83.11.757", "2041050"]}, {"Citation": "Grever M.R., Schepartz S.A., Chabner B.A. The National-Cancer-Institute: Cancer drug discovery and development program. Semin. Oncol. 1992;19:622\u2013638.", "ArticleIdList": ["1462164"]}, {"Citation": "Sever B., Altintop M.D., Ozdemir A., Akalin Ciftci G., Ellakwa D.E., Tateishi H., Radwan M.O., Ibrahim M.A.A., Otsuka M., Fujita M., et al. In vitro and in silico evaluation of anticancer activity of new indole-based 1,3,4-oxadiazoles as EGFR and COX-2 inhibitors. Molecules. 2020;25:5190. doi: 10.3390/molecules25215190.", "ArticleIdList": ["10.3390/molecules25215190", "PMC7664637", "33171861"]}, {"Citation": "Ciftci H.I., Radwan M.O., Sever B., Hamdy A.K., Emirda\u011f S., Ulusoy N.G., Sozer E., Can M., Yayli N., Araki N., et al. EGFR-targeted pentacyclic triterpene analogues for glioma therapy. Int. J. Mol. Sci. 2021;22:10945. doi: 10.3390/ijms222010945.", "ArticleIdList": ["10.3390/ijms222010945", "PMC8537327", "34681605"]}, {"Citation": "Zeyt\u00fcn E., Alt\u0131ntop M.D., Sever B., \u00d6zdemir A., Ellakwa D.E., Ocak Z., Ciftci H.I., Otsuka M., Fujita M., Radwan M.O. A new series of antileukemic agents: Design, synthesis, in vitro and in silico evaluation of thiazole-based ABL1 kinase inhibitors. Anticancer Agents Med. Chem. 2021;21:1099\u20131109. doi: 10.2174/1871520620666200824100408.", "ArticleIdList": ["10.2174/1871520620666200824100408", "32838725"]}, {"Citation": "Ciftci H.I., Can M., Ellakwa D.E., Suner S.C., Ibrahim M.A., Oral A., Sekeroglu N., \u00d6zalp B., Otsuka M., Fujita M., et al. Anticancer activity of Turkish marine extracts: A purple sponge extract induces apoptosis with multitarget kinase inhibition activity. Investig. New Drugs. 2020;38:1326\u20131333. doi: 10.1007/s10637-020-00911-8.", "ArticleIdList": ["10.1007/s10637-020-00911-8", "32062733"]}, {"Citation": "Tateishi H., Monde K., Anraku K., Koga R., Hayashi Y., Ciftci H.I., DeMirci H., Higashi T., Motoyama K., Arima H., et al. A clue to unprecedented strategy to HIV eradication: \u201cLock-in and apoptosis\u201d. Sci. Rep. 2017;7:8957. doi: 10.1038/s41598-017-09129-w.", "ArticleIdList": ["10.1038/s41598-017-09129-w", "PMC5567282", "28827668"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "13"}, {"Year": "2022", "Month": "1", "Day": "15"}, {"Year": "2022", "Month": "1", "Day": "18"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "1", "Minute": "19"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35163957", "PMC8839215", "10.3390/molecules27030693", "molecules27030693"]}}], "PubmedBookArticle": []}